Use of antibodies or antibody-drug conjugates in combination with other therapeutic agents
TW202629254APending Publication Date: 2026-07-16SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF -1 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
- Filing Date
- 2025-10-14
- Publication Date
- 2026-07-16
Abstract
The use of an antibody-drug conjugate with other therapeutic agents or a composition of an antibody-drug conjugate with other therapeutic agents in the preparation of a medicament for treating tumors or cancer; wherein the other therapeutic agents are selected from one or more of anti-EGFR antibodies and anti-VEGF antibodies; wherein the antibody-drug conjugate is an antibody-drug conjugate targeting B7-H3, and the composition of the antibody-drug conjugate comprises one or more of the antibody-drug conjugates.
Need to check novelty before this filing date? Find Prior Art